The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Tuberculosis, Drug Resistance, and the History of Modern Medicine
Abstract
Mycobacterium tuberculosis has been a major cause of human disease for centuries. This article discusses the development of active drug therapy and the emergence and dissemination of drug-resistant strains. Failure to manage tuberculosis properly puts us all at risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
World development report 1993 : investing in health
Berkley, S., Bobadilla, J., Hecht, R., Hill, K., Jamison, D. T. T., Murray, C. J. L., Musgrove, P., Saxenian, H., & Tan, J. (1993) · Cited by 2,410
Quantifying the burden of disease: the technical basis for disability-adjusted life years.
Murray, C. J. L. (1994) · Europe PMC (PubMed Central) · Cited by 1,581
Bank, W. (1993) · doi:10.1596/978-0-1952-0890-0 · Cited by 1,048
Selective Primary Health Care: An Interim Strategy for Disease Control in Developing Countries
Walsh, J. A., & Warren, K. S. (1979) · New England Journal of Medicine · doi:10.1056/nejm197911013011804 · Cited by 1,034
Streptomycin Treatment of Pulmonary Tuberculosis: A Medical Research Council Investigation
(1948) · BMJ · doi:10.1136/bmj.2.4582.769 · Cited by 986
Infections and inequalities: the modern plagues
(2001) · Choice Reviews Online · doi:10.5860/choice.38-3356 · Cited by 958
Fox, W., Ellard, G. A., & Mitchison, D. A. (1999) · PubMed · Cited by 797
Tuberculosis in New York City — Turning the Tide
Frieden, T. R., Fujiwara, P. I., Washko, R. M., & Hamburg, M. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330406 · Cited by 640
STREPTOMYCIN treatment of pulmonary tuberculosis.
D’Esopo, N. D., & Allison, S. T. (1947) · PubMed · Cited by 606
Totally Drug-Resistant Tuberculosis in India
Udwadia, Z. F., Amale, R. A., Ajbani, K. K., & Rodrigues, C. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir889 · Cited by 527
Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, Peru
Mitnick, C., Bayona, J., Palacios, E., Shin, S., Furin, J., Alcántara, F., Sánchez, E., Sarria, M., Becerra, M., Fawzi, M. C. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022928 · Cited by 489
Self-citationBifani, P. J. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530300036037 · Cited by 381
Social scientists and the new tuberculosis
Farmer, P. (1997) · Social Science & Medicine · doi:10.1016/s0277-9536(96)00143-8 · Cited by 305
Self-citationLeimane, V., Riekstina, V., Holtz, T. H., Zarovska, E., Skripconoka, V., Thorpe, L. E., Laserson, K. F., & Wells, C. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17786-1 · Cited by 279
Exogenous Reinfection with Tuberculosis in a Shelter for the Homeless
Nardell, E., McInnis, B., Thomas, B., & Weidhaas, S. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612183152502 · Cited by 265
Streptomycin Resistance in Pulmonary Tuberculosis
Crofton, J., & Mitchison, D. A. (1948) · BMJ · doi:10.1136/bmj.2.4588.1009 · Cited by 261
The Treatment of Multidrug-Resistant Tuberculosis in Turkey
Tahaoğlu, K., Törün, T., Sevim, T., Ataç, G., Kir, A., Karasulu, L., Özmen, İ., & Kapaklı, N. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450303 · Cited by 248
Suárez, P. G., Floyd, K., Portocarrero, J., Alarcón, E., Rapiti, E., Ramos, G., Bonilla, C., Sabogal, I., Aranda, I., Dye, C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08830-x · Cited by 211
Selective primary health care: A critical review of methods and results
Unger, J., & Killingsworth, J. R. (1986) · Social Science & Medicine · doi:10.1016/0277-9536(86)90200-5 · Cited by 187
TREATMENT OF TUBERCULOSIS WITH STREPTOMYCIN: A Summary of Observations on One Hundred Cases
Hinshaw, H. C. (1946) · JAMA · doi:10.1001/jama.1946.02870480024007 · Cited by 178
Suárez, Floyd, Portocarrero, & Alarcon (2002) · The Lancet · Cited by 166
Responding to Market Failures in Tuberculosis Control
Gupta, R., Kim, J. Y., Espinal, M., Caudron, J.-M., Pécoul, B., Farmer, P. E., & Raviglione, M. C. (2001) · Science · doi:10.1126/science.1061861 · Cited by 136
Self-citationKimerling, M. E., Kluge, H. H. P., Vezhnina, N., Iacovazzi, T., Demeulenaere, T., Portaels, F., & Matthys, F. (1999) · PubMed · Cited by 133
Selective primary health care: Old wine in new bottles
Gish, O. (1982) · Social Science & Medicine · doi:10.1016/0277-9536(82)90177-0 · Cited by 124
TREATMENT OF PULMONARY TUBERCULOSIS WITH HYDRAZIDE DERIVATIVES OF ISONICOTINIC ACID
Selikoff, I. J. (1952) · JAMA · doi:10.1001/jama.1952.03680100015006 · Cited by 124
Captain of death: the story of tuberculosis
(1998) · Choice Reviews Online · doi:10.5860/choice.35-5685 · Cited by 113
Fox, W., Wiener, A., Mitchison, D. A., Selkon, J. B., & Sutherland, I. (1957) · Tubercle · doi:10.1016/s0041-3879(57)80001-4 · Cited by 100
Becerra, M. C., Freeman, J., Bayona, J. N., Shin, S. S., Kim, J. Y., Furin, J. J., Werner, B., Sloutsky, A., Timperi, R., Wilson, M. E., et al. (2000) · PubMed · Cited by 91
Self-citationExtensively Drug‐Resistant Tuberculosis: “There must be some kind of way out of here”
Cegielski, J. P. (2010) · Clinical Infectious Diseases · doi:10.1086/651491 · Cited by 85
Selective primary health care: Is efficient sufficient?
Berman, P. (1982) · Social Science & Medicine · doi:10.1016/0277-9536(82)90178-2 · Cited by 74
Tuberculosis control--is DOTS the health breakthrough of the 1990s?
Kochi, A. (1997) · PubMed · Cited by 74
Beyond the World Bank agenda : an institutional approach to development
Stein, H. (2008) · doi:10.7208/9780226771656 · Cited by 70
Migliori, G. B., Espinal, M., Danilova, I. D., Пунга, В. В., Grzemska, M., & Raviglione, M. C. (2002) · PubMed · Cited by 70
Rifampin in the Treatment of Drug-ResistantMycobacterium tuberculosisInfections
Vall-Spinosa, A., Lester, W. T., Moulding, T., Davidson, P. T., & McClatchy, J. K. (1970) · New England Journal of Medicine · doi:10.1056/nejm197009172831202 · Cited by 58
Picking Up the Pace — Scale-Up of MDR Tuberculosis Treatment Programs
Keshavjee, S. A., & Farmer, P. E. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1010023 · Cited by 56
Self-citationKim, J. Y., Mukherjee, J. S., Rich, M., Mate, K. S., Bayona, J. N., & Becerra, M. C. (2003) · Tuberculosis · doi:10.1016/s1472-9792(02)00078-1 · Cited by 56
Development of Drug Resistance to Rifampicin
Manten, A., & Wijngaarden, L. J. V. (2009) · Chemotherapy · doi:10.1159/000220615 · Cited by 53
Han, L., Sloutsky, A., Canales, R., Naroditskaya, V., Shin, S. S., Seung, K. J., Timperi, R., & Becerra, M. C. (2005) · PubMed · Cited by 43
The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis.
Villarino, M. E., Geiter, L. J., & Simone, P. M. (1992) · Europe PMC (PubMed Central) · Cited by 43
Primary Drug-Resistant Tuberculosis
Steiner, M., Chaves, A. D., Lyons, H. A., Steiner, P., & Portugaleza, C. (1970) · New England Journal of Medicine · doi:10.1056/nejm197012172832501 · Cited by 42
Vásquez-Campos, L., Asencios-Solís, L., Hurtado, E. L., Quispe-Torres, N., Salazar‐Lindo, E., Bayona, J. N., & Mc, B. (2004) · PubMed · Cited by 28
Castro, K. G., & LoBue, P. A. (2011) · Emerging infectious diseases · doi:10.3201/eid1703.110031 · Cited by 22
Time to put boots on the ground: making universal access to MDR-TB treatment a reality.
Keshavjee, S. A., & Farmer, P. E. (2010) · PubMed · Cited by 18
Self-citationThe Rise of Tuberculosis in America before 1820
Holmberg, S. D. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.5.1228 · Cited by 16
Rifampin — A Major New Chemotherapeutic Agent for the Treatment of Tuberculosis
Daniel, T. M. (1969) · New England Journal of Medicine · doi:10.1056/nejm196903132801112 · Cited by 12
Streptomycin in the Treatment of Extrapulmonary Tuberculosis
Jellinek, K. (1949) · New England Journal of Medicine · doi:10.1056/nejm194904282401703 · Cited by 7
Cited by
Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis
Seung, K. J., Keshavjee, S., & Rich, M. L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017863 · Cited by 805
Self-citationTackling Threats and Future Problems of Multidrug-Resistant Bacteria
Medina, E., & Pieper, D. H. (2016) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2016_492 · Cited by 356
Tuberculosis: A disease without boundaries
Fogel, N. (2015) · Tuberculosis · doi:10.1016/j.tube.2015.05.017 · Cited by 328
Marais, B. J., Lönnroth, K., Lawn, S. D., Migliori, G. B., Mwaba, P., Glaziou, P., Bates, M., Colagiuri, R., Zijenah, L., Swaminathan, S., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70015-x · Cited by 314
Gideon, H. P., Hughes, T. K., Tzouanas, C. N., Wadsworth, M. H., Tu, A. A., Gierahn, T. M., Peters, J. M., Hopkins, F. F., Wei, J.-R., Kummerlowe, C., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.004 · Cited by 278
Metadata
- Authors
- Keshavjee, S., & Farmer, P. E.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-09-06
- Volume
- 367
- Issue
- 10
- Pages
- 931-936
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2099939307
- Cited by
- 315
- References
- 47
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.